Listed

Celsius Holdings, Inc.: Form 10-Q for the period ended Mar 31, 2022

Filed with the SEC on May 10, 2022 and accepted by EDGAR at May 10, 2022, 16:03 ET.

Share

Management's discussion and analysis

As filed, 13,037 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

When used in this report, unless otherwise indicated, the terms “the Company,” “Celsius,” “we,” “us” and “our” refer to Celsius Holdings, Inc. and its subsidiaries.

Note Regarding Forward Looking Statements

This report contains forward-looking statements that reflect our current views about future events. We use the words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Business Overview

Celsius Holdings is a fast-growing company in the functional energy drink and liquid supplement categories in the United States and internationally. We engage in the development, processing, marketing, sale, and distribution of functional drinks and liquid supplements to a broad range of consumers. We believe that we provide differentiated products that offer clinically proven and innovative formulas meant to change the lives of our consumers for the better. We also believe that our brand is attractive to a broad range of customers including fitness enthusiasts.

Our core offerings include pre- and post-workout functional energy drinks, as well as protein bars. Our flagship functional energy drink and liquid supplement brands are backed by science, being clinically proven to deliver health benefits by six self-funded studies published in various journals including the Journal of the International Society of Sports Nutrition, the Journal of the American College of Nutrition, and the Journal of Strength and Conditioning Research. These studies have concluded that a single serving of Celsius burns 100-140 calories (by increasing a consumer’s resting metabolism an average of 12%, while providing sustained energy for up to three hours).

Our flagship asset, Celsius, is a fitness supplement drink which accelerates metabolism and burns calories and body fat while providing energy. This product line comes in two versions, a ready-to-drink supplement format and an on-the-go powder form. We also offer a Celsius Heat and a Branch Chain Amino Acids line, catered to both pre- and post-workout consumer needs. Our products are currently offered in major retail channels in the US including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce.

An integral part of our value proposition is our focus on the functional energy drink and liquid supplement category, ensuring our products have clear and proven benefits. This is why we invest in research and development from the start and utilize our proprietary MetaPlus formulation in our portfolio, a blend of ginger root, guarana seed extract, chromium, vitamins, and green tea extract.

Corporate Information

We were incorporated in the State of Nevada in April 2005. Our principal executive offices are located at 2424 North Federal Highway, Suite 208, Boca Raton, Florida 33431, and our telephone number is (561) 276-2239. Our website is www.celsiusholdingsinc.com (http://www.celsiusholdingsinc.com). Information contained on, or that can be accessed through, our website is not incorporated by reference into this Quarterly Report on Form 10-Q.

Celsius® and MetaPlus® are registered trademarks of the Company in the United States. This Quarterly Report on Form 10-Q also contains other registered and unregistered trademarks of the Company.

Results of Operations

Three months ended March 31, 2022 compared to three months ended March 31, 2021

Revenue

For the three months ended March 31, 2022, revenue was approximately $133.4 million, an increase of $83.4 million or 167% from $50.0 million for the three months ended March 31, 2021. Approximately 101% of this growth was as a result of increased revenues from North America, where first quarter 2022 revenues were $123.5 million, an increase of $84.5 million or 217% from the 2021 quarter. The balance of the revenues for the 2022 quarter were mainly attributable to European revenues of $8.5 million, which were slightly below the prior year quarter primarily due to foreign exchange rates and timing. Asian revenues (which include royalty revenues from our China licensee) contributed an additional approximately $1.0 million, an increase of 80% from approximately $0.5 million for the prior year quarter, which include increases in royalties payable under our licensing agreement. Other international markets generated approximately $0.5 million in revenues during the three months ended March 31, 2022, an increase of $0.3 million or 255% from $0.1 million for the prior year quarter.

The total increase in revenue was largely attributable to increases in sales volume, as opposed to increases in product pricing. The primary factors behind the increase in North American sales volume were related to continued strong triple-digit growth in traditional distribution channels, combined with an increase in and optimization of our products’ presence in world class retailers (e.g., additional SKUs). Additionally, the continued expansion of our Direct Store Delivery (“DSD”) network resulted in significant growth in distributor revenues when compared to the prior year quarter.

The following table sets forth the amount of revenues by category and changes therein for the three months ended March 31, 2022 and March 31, 2021 (dollars in thousands):

Revenue Source Three months ended March 31, 2022 2021 Change
Total Revenue $133,388 $50,035 166.6%
North American Revenue $123,473 $39,003 216.6%
European Revenue $8,495 $10,368 (18.1)%
Asian Revenue $966 $536 80.2%
Other $454 $128 254.7%

Gross profit

For the three months ended March 31, 2022, gross profit increased by approximately $33.3 million or 162% to $53.9 million, from $20.6 million for the three months ended March 31, 2021. Gross profit margins reflected a decrease to 40.4% for the three months ended March 31, 2022 from 41.1% for the 2021 quarter. The increase in gross profit dollars is related to increases in volume, while the decrease in gross profit margins is mainly related to higher raw material costs (particularly aluminum cans), ocean freight costs, transportation costs and repackaging costs.

We estimate that the increase in gross profit dollars of approximately $33.3 million from the 2021 quarter to the 2022 quarter, included $34.3 million related to volume increases, as well as an unfavorable cost impact of approximately $0.9 million and unfavorable currency impact of $0.1 million.

Sales and marketing expenses

Sales and marketing expenses for the three months ended March 31, 2022 were approximately $31.6 million, an increase of approximately $19.6 million or 164% from approximately $12.0 million for the three months ended March 31, 2021. This increase was primarily attributable to higher marketing investment activities, which resulted in an increase of $9.1 million when compared to the prior year quarter. Additionally, employee costs increased by approximately $1.4 million from the year ago quarter as we continue to invest in this area in order to have the proper infrastructure to support our growth. Lastly, storage and distribution expenses as well as broker costs accounted for the remainder of the increase in this area in the amount of $9.1 million from the 2021 quarter to the 2022 quarter.

General and administrative expenses

General and administrative expenses for the three months ended March 31, 2022 were approximately $12.2 million, an increase of $4.4 million or 56%, from $7.8 million for the three months ended March 31, 2021. This increase was primarily attributable to stock option expense which amounted to $4.3 million for the three months ended March 31, 2022, an increase of $0.7 million which accounts for 17.8% of the total increase in this area when compared to the prior year quarter. Management deems it very important to motivate employees by providing them ownership in the business in order to promote over performance which translates into the continued success of our business based on key performance attributes. Additionally, employee costs for the three months ended March 31, 2022 reflect an increase of $1.2 million or 76.2%, as investments in this area are also required to properly support our higher business volume and the commercial and operational areas of the business, as well as travel expenses are now being incurred. Administrative expenses amounted to $4.5 million or an increase of $2.4 million or 116%, when compared to the prior year quarter. The additional administrative expenses are mainly related to an increase in bad debt reserve of $0.2 million and increases in audit costs, legal expenses, insurance costs and office rent account for the majority of the remaining fluctuation of $2.2 million. Depreciation and amortization increased by approximately $0.1 million when compared to the prior year quarter. Lastly, all other administrative expenses which were mainly composed of research, development and quality control testing, decreased by approximately $0.1 million from to the first quarter of 2021.

Other income/(expense)

Total net other expense for the three months ended March 31, 2022 is mainly related to foreign currency exchange which is offset by interest and non-operating income.

Net Income

Net income for the three months ended March 31, 2022 was $6.7 million or $0.09 per share based on a weighted average of 75,239,292 shares outstanding and dilutive earnings per share of $0.09 based on a fully-dilutive weighted average of 78,289,228 shares outstanding, which includes the dilutive impact share-based awards of 3,049,936 shares. In comparison, for the three months ended March 31, 2021, the Company had net income of approximately $0.6 million or $0.01 per share, based on a weighted average of 72,516,296 shares outstanding and a dilutive earnings per share of $0.01 based on a fully-dilutive weighted average of 76,925,484 shares outstanding.

Liquidity and Capital Resources

As of March 31, 2022, and December 31, 2021, we had cash of approximately $25.5 million and $16.3 million, respectively, and working capital of approximately $186.5 million and $169.2 million, respectively.

In addition to cash flow from operations, our primary sources of working capital have been private placements and public offerings of our securities, including an underwritten public offering of 1,133,953 shares at an offering price of $62.50 per share completed on June 14, 2021 and a private placement of 1,437,909 shares at a price of $15.30 completed on August 25, 2020.

Our current operating plan for the next twelve (12) months reflects sufficient financial resources, notwithstanding the potential effects of the COVID-19 pandemic.

Cash flows used in operating activities

Cash flows provided by operating activities totaled approximately $9.1 million for the three months ended March 31, 2022, which compares to $13.3 million net cash used in operating activities for the three months ended March 31, 2021. The approximately $22 million increase in cash generation was driven by an increase in net income and improvements in working capital. Working capital improvements were driven primarily by the stabilization of our inventory as we have established optimal levels to service the demand of our product as well as timing of accounts payable, offset in part by increases of accounts receivable driven by the significant growth in our business.

Cash flows used in investing activities

Cash flows used in investing activities totaled approximately $0.7 million for the three months ended March 31, 2022, which compares to cash provided by investing activities of $1.2 million for the three months ended March 31, 2021. The decrease in the cash provided by investing activities when compared to the 2021 period was primarily due to the timing of payment on our note receivable, as we received payment on our note receivable of approximately $2.6 million in April 2022.

Cash flows provided by financing activities

Cash flows provided by financing activities totaled approximately $0.8 million for the three months ended March 31, 2022, which compares to cash provided by financing activities of $0.7 million for the three months ended March 31, 2021. The increase of cash provided by financing activities is mainly related to the net proceeds of $0.8 million from stock exercises.

Off Balance Sheet Arrangements

As of March 31, 2022 and December 31, 2021, we had no off-balance sheet arrangements.

Market risk

As filed, 1,062 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In the normal course of business our financial position is routinely subject to a variety of risks. The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which we are exposed are fluctuations in commodity and other input prices affecting the costs of our raw materials (including, but not limited to, increases in the costs of the price of aluminum cans, sucralose and other sweeteners, as well as other raw materials contained within our products). We generally do not use hedging agreements or alternative instruments to manage the risks associated with securing sufficient ingredients or raw materials. We are also subject to market risks with respect to the cost of commodities and other inputs because our ability to recover increased costs through higher pricing is limited by the competitive environment in which we operate.

We do not use derivative financial instruments to protect ourselves from fluctuations in interest rates and generally do not hedge against fluctuations in commodity prices.

Controls and procedures

As filed, 7,622 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Management’s Report on Disclosure Controls and Procedures

Our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial and accounting officer), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of March 31, 2022, to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the SEC, including to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our Chief Executive Officer and our Chief Financial Officer do not expect that our disclosure controls or internal controls will prevent all error and all fraud. Although our disclosure controls and procedures were designed to provide reasonable assurance of achieving their objectives and our Chief Executive Officer and our Chief Financial Officer have determined that our disclosure controls and procedures are effective at doing so, a control system, no matter how well conceived and operated, can provide only reasonable, not absolute assurance that the objectives of the system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented if there exists in an individual a desire to do so. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

We identified material weaknesses as of December 31, 2021 in our internal controls over financial reporting, which were not fully remedied as of March 31, 2022. A material weakness is a deficiency or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected and corrected on a timely basis. As a result of these material weaknesses, we concluded that internal controls over the following areas were not effective as of December 31, 2021 and were not fully remedied as of March 31, 2022.

a) Management failed to design effective controls related to the application of U.S. GAAP guidance in their evaluation of modifications to share-based payment arrangements, resulting in the correction of errors in previously issued interim financial statements relating to the recognition of compensation expense described above;

b) For a substantial portion of the year, management did not design and maintain effective controls over information technology general controls (ITGCs) for information systems and applications that are relevant to the preparation of the consolidated financial statements. Specifically, management did not design and maintain: sufficient user access controls to ensure appropriate segregation of duties and adequately restrict user and privileged access to financial applications, programs and data to appropriate Company personnel; program change management controls to ensure that information technology (IT) program and data changes affecting financial information technology applications and underlying accounting records are authorized, tested, and implemented appropriately. As a result, business process controls (automated and it-dependent manual controls) that are dependent on the ineffective ITGCs, or that use data produced from systems impacted by the ineffective ITGCs were deemed ineffective at December 31 2021; and

c) Management did not have an adequate process in place to monitor and provide oversight over the completion of its testing and assessment of the design and operating effectiveness of internal control over financial reporting in a timely manner. As such, we determined that management failed to fully implement components of the COSO framework, including elements of the control environment, information and communication, control activities and monitoring activities components, relating to: (i) providing sufficient and timely management oversight and ownership over the internal control evaluation process; (ii) hiring and training sufficient personnel to timely support the Company’s internal control objectives; (iii) performing timely monitoring and oversight to ascertain whether the components of internal control are present and functioning effectively.

To address the issues associated with our material weaknesses as described above, management is re-assessing the design of controls and modifying processes designed to improve our internal control over financial reporting and remediate the control deficiencies that led to the material weaknesses, including but not limited to, (a) enhancing monitoring and oversight controls in the application of U.S. GAAP guidance pertaining to modifications of share-based payments, (b) hiring additional accounting and IT personnel with appropriate technical skillsets, (c) improving consistency in change management supported by standard operating procedures to govern the authorization, testing and approval of changes to information technology systems supporting all of the Company’s internal control processes, (d) enhancing design and implementation of our control environment, including the expansion of formal accounting and IT policies and procedures and financial reporting controls, and (e) implementing appropriate timely review and oversight responsibilities within the accounting and financial reporting functions. However, as of March 31, 2022, the identified material weaknesses were not fully remedied.

Changes in Internal Controls Over Financial Reporting

During the first quarter of 2022, we have been implementing and will aggressively continue to implement changes that are both organizational and process-focused to improve the control environment. We anticipate the actions to be taken, and resulting process improvements, to generally strengthen our internal controls over financial reporting, information technology general controls as well as our controls around share-based payments, and over time, will address the material weakness noted as of December 31, 2021. These remedial measures were considered changes to our internal control environment which had a material effect on internal control over financial reporting. However, because certain of the remedial actions have only recently been undertaken and others will occur over the next several months, we have concluded that our controls and procedures in the areas listed above were not effective as of March 31, 2022. We will not be able to conclude that the material weaknesses have been eliminated until the completion of the December 31, 2022 annual report on form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-01 to 2022-03-31$133.4mus-gaap:Revenues
Cost of revenue3 months2022-01-01 to 2022-03-31$79.5mus-gaap:CostOfRevenue
Gross profit3 months2022-01-01 to 2022-03-31$53.9mus-gaap:GrossProfit
Research and development3 months2022-01-01 to 2022-03-31$100.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-01-01 to 2022-03-31$10.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-01-01 to 2022-03-31$2.0kus-gaap:InterestExpense
Income tax3 months2022-01-01 to 2022-03-31$3.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-01-01 to 2022-03-31$6.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-01-01 to 2022-03-31$0.09us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-01-01 to 2022-03-31$0.09us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-01-01 to 2022-03-3178,289,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-01-01 to 2022-03-31$9.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-01 to 2022-03-31$742.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-03-31$25.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-03-31$298.2mus-gaap:AssetsCurrent
Total assetsAt period end2022-03-31$343.9mus-gaap:Assets
Current liabilitiesAt period end2022-03-31$111.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-03-31$115.6mus-gaap:Liabilities
Shareholders' equityAt period end2022-03-31$228.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000950170-22-008947. Last ingested by Listed: Nov 10, 2026, 02:33 ET. Listed shows no prices and gives no investment advice.